SMAD3 and Cerebral cortical atrophy: In antemortem studies, we demonstrated associations of SMAD3 locus genetic variants with both higher blood levels of this gene and lower frequency of brain infarcts, as well as correlations of high blood SMAD3 with lower brain amyloid β and less cortical atrophy.